Lummis Asset Management, LP

Position in JNJ — Johnson & Johnson

CIK 2011652 FORT WORTH, TX

Position in JNJ

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$3,263,260

+$116,584 QoQ

Shares Held

12,849

-0.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.18%

of 13F equity value

Holder Rank

#1,936

of 4,664 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Lummis Asset Management, LP holds $9,288,276 across 6 Drug Manufacturers - General names. JNJ ranks #1 (35.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	12,849	$3,263,260
2	LLY	ELI LILLY & Co	2,675	$3,208,475
3	ABBV	AbbVie Inc.	6,229	$1,567,465
4	AMGN	Amgen Inc	3,433	$1,243,157
5	SNY	Sanofi	80	$3,412
6	NVS	Novartis AG	16	$2,507

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,263,260	12,849	-0.2%	Shares	Sole	2026-08-03
2026-03-31	$3,146,676	12,873	-3.7%	Shares	Sole	2026-05-11
2025-12-31	$2,767,542	13,373	-1.6%	Shares	Sole	2026-02-10
2025-09-30	$2,518,745	13,584	-0.1%	Shares	Sole	2025-11-10
2025-06-30	$2,077,094	13,598	-1.1%	Shares	Sole	2025-08-11
2025-03-31	$2,279,139	13,743	+119.8%	Shares	Sole	2025-05-15
2024-12-31	$904,308	6,253	-0.0%	Shares	Sole	2025-01-15
2024-09-30	$1,013,685	6,255	0.0%	Shares	Sole	2024-11-06
2024-06-30	$914,230	6,255	-0.6%	Shares	Sole	2024-08-14
2024-03-31	$995,015	6,290	-54.6%	Shares	Sole	2024-05-17
2023-12-31	$2,172,102	13,858	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.